Dr. Mònica Mir, researcher at the Nanobioengineering Group at IBEC and leader of the Caixa Impulse funded project ISCHEMSURG, explained on World Transplant Day how this electrochemical sensor can monitor ischemia in transplanted tissue thus, improving transplant patients’ quality of life.
How did the ISCHEMSURG project take shape?
The project was born after speaking with medical doctors who told us about the problems they were having monitoring postoperative ischemia—an inadequate supply of blood—in transplanted tissue.
Nuria Montserrat, Group Leader at IBEC and ICREA Research Professor, meets with the Minister of Science and Innovation, Pedro Duque, to present her ACE2-ORG project, which seeks, by using organoids generated from bioengineering techniques, possible therapeutic solutions against the SARS-CoV-2 virus.
The Minister of Science and Innovation held a videoconference meeting this Thursday, June 18, with the responsibles of five research projects that are working on the development of new technologies to deal with SARS-CoV-2 and which are being financed by the Fund COVID-19, managed by the Carlos III Health Institute (ISCIII).
The Institute for Bioengineering of Catalonia (IBEC) is the first research center to take part in the “Creative talent and Business” initiative launched by the Catalan Government.
Bioengineering involves addressing, understanding and solving highly complex problems in biomedicine. Research in nanomedicine, cell and tissue engineering, and new technologies for health will greatly change the way we face medical challenges.
An international committee has elected Samuel Sánchez, the European referent in nanomotors, as one of the new 13 researchers, among 185 candidates, who will be a member of the Young Academy of Spain.
Last Thursday, May 28, the General Board of the Young Academy of Spain elected 13 new academic members. An independent international committee composed of highly prestigious researchers from different areas of knowledge participated in the selection process.
Last March Alex Pachón, a stutent that did his research project at IBEC won the CRACKS Prize awarded each year by the University of Girona (UdG) thanks to his School Research Project on nanobiotechnology applied to cancer medicine. Filotea Crasovan won the Foro de Gracia contest.
Alex’s work, entitled ‘The secret of oncological medicine hidden in the nanoworld’, is one of the 25 school research projects tutored last year by IBEC researchers.
Bioengineering is a core discipline for the medicine of the future, and Europe knows that. Proof of this is that the European Union (EU) has granted during the last months the coordination of three European projects to the Institute for Bioengineering of Catalonia (IBEC) to continue combining medicine, science and technology with the aim of improving people’s health.
The first one is the BRIGHTER project that is led by Professor Elena Martínez, the head of the ‘Biomimetic Systems for Cell Engineering’ group. The EU has contributed to this initiative that will be used by the consortium partners to develop an innovative high resolution 3D bioprinting technology able to fabricate 3D cell culture substrates which could be useful to produce artificial organs in the future.
Fifty undergraduate and master students attended this year’s reSearch4Talent, this is the sixth time we’ve opened our doors to young scholars interested in a scientific career, but this time, virtually.
In 2019 IBEC signed more than 145 internship agreements for Undergraduate and Master Students who are at a key moment in their careers with a wide range of national and international universities.
The Mayor of Barcelona, Ada Colau, visited IBEC facilities last Friday to learn, by our Director and a group of researchers, how bioengineering can help find solutions to health problems such as COVID19, cancer, or degenerative diseases.
When in early 2020, more than 200 scientists gathered in La Pedrera in Barcelona to discuss the present and future of bioengineering, no one imagined that the world would experience the first pandemic of the 21st century and that science would take on more importance than ever.
The Center for Genomic Regulation (CRG), the National Center for Genomic Analysis (CNAG-CRG), part of CRG, the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC) have analysed more than 20,000 samples to date using the PCR technique. In this regard, 17,547 samples have been tested at the CRG node and 5,248 at the PCB node.
The analyses are part of the Orfeu Programme, the mass screening initiative driven by the Government of Catalonia. As of today, the public health system in Catalonia can carry out up to 17,000 PCR tests every day. This number does not include the capacity of the Orfeu Programme, which can process up to 4,000 samples per day.
The COVID-19 Fund managed by the Carlos III Health Institute has awarded more than 300,000 euros to the “ACE2-ORG” project led by ICREA research professor Núria Montserrat at IBEC.
The resources are intended to study COVID-19 and specify new therapeutic approaches against the SARS-CoV-2 coronavirus, the Karolinska Institute in Sweden, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, the Hospital Clínic de Barcelona and the University of Navarra also participate in this project.